Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Diagnostic Performance of 1,5-Anhydroglucitol Compared to 2-H Glucose in the Atherosclerosis Risk in Communities Study.

Warren B, Lee AK, Ballantyne CM, Hoogeveen RC, Pankow JS, Grams M, Köttgen A, Selvin E.

Clin Chem. 2018 Oct;64(10):1536-1537. doi: 10.1373/clinchem.2018.291773. Epub 2018 Aug 7. No abstract available.

PMID:
30087139
2.

A Cost Benefit Analysis of an Active Travel Intervention with Health and Carbon Emission Reduction Benefits.

Chapman R, Keall M, Howden-Chapman P, Grams M, Witten K, Randal E, Woodward A.

Int J Environ Res Public Health. 2018 May 11;15(5). pii: E962. doi: 10.3390/ijerph15050962.

3.

Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease.

Lamprea-Montealegre JA, McClelland RL, Grams M, Ouyang P, Szklo M, de Boer IH.

Heart. 2018 Sep;104(17):1455-1460. doi: 10.1136/heartjnl-2017-312794. Epub 2018 Feb 22.

PMID:
29472290
4.

Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.

Jung M, Warren B, Grams M, Kwong YD, Shafi T, Coresh J, Rebholz CM, Selvin E.

J Diabetes. 2018 Apr;10(4):276-285. doi: 10.1111/1753-0407.12618. Epub 2017 Dec 21.

5.

Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study.

Warren B, Rawlings AM, Lee AK, Grams M, Coresh J, Selvin E.

Diabetes Care. 2017 Aug;40(8):e96-e97. doi: 10.2337/dc17-0075. Epub 2017 May 15. No abstract available.

6.

Head and Neck Radiation Dose and Radiation Safety for Interventional Physicians.

Fetterly K, Schueler B, Grams M, Sturchio G, Bell M, Gulati R.

JACC Cardiovasc Interv. 2017 Mar 13;10(5):520-528. doi: 10.1016/j.jcin.2016.11.026.

7.

Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.

Inker LA, Coresh J, Sang Y, Hsu CY, Foster MC, Eckfeldt JH, Karger AB, Nelson RG, Liu X, Sarnak M, Appel LJ, Grams M, Xie D, Kimmel PL, Feldman H, Ramachandran V, Levey AS; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):69-78. doi: 10.2215/CJN.03660316. Epub 2016 Nov 10.

8.

Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.

Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, Woodward M, Selvin E.

Lancet Diabetes Endocrinol. 2017 Jan;5(1):34-42. doi: 10.1016/S2213-8587(16)30321-7. Epub 2016 Nov 16.

9.

Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.

Chang AR, Evans M, Yule C, Bohn L, Young A, Lewis M, Graboski E, Gerdy B, Ehmann W, Brady J, Lawrence L, Antunes N, Green J, Snyder S, Kirchner HL, Grams M, Perkins R.

BMC Nephrol. 2016 Nov 8;17(1):168.

10.

Incident chronic kidney disease: trends in management and outcomes.

Perkins RM, Chang AR, Wood KE, Coresh J, Matsushita K, Grams M.

Clin Kidney J. 2016 Jun;9(3):432-7. doi: 10.1093/ckj/sfw044. Epub 2016 May 25.

11.

Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study.

Mok Y, Matsushita K, Sang Y, Ballew SH, Grams M, Shin SY, Jee SH, Coresh J.

PLoS One. 2016 Apr 19;11(4):e0153429. doi: 10.1371/journal.pone.0153429. eCollection 2016.

12.

Gout in Older Adults: The Atherosclerosis Risk in Communities Study.

Burke BT, Köttgen A, Law A, Grams M, Baer AN, Coresh J, McAdams-DeMarco MA.

J Gerontol A Biol Sci Med Sci. 2016 Apr;71(4):536-42. doi: 10.1093/gerona/glv120. Epub 2015 Dec 28.

13.

Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction.

Sharma K, Hill T, Grams M, Daya NR, Hays AG, Fine D, Thiemann DR, Weiss RG, Tedford RJ, Kass DA, Schulman SP, Russell SD.

Am J Cardiol. 2015 Nov 15;116(10):1534-40. doi: 10.1016/j.amjcard.2015.08.019. Epub 2015 Aug 31.

PMID:
26410603
14.

Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Foster MC, Coresh J, Bonventre JV, Sabbisetti VS, Waikar SS, Mifflin TE, Nelson RG, Grams M, Feldman HI, Vasan RS, Kimmel PL, Hsu CY, Liu KD; CKD Biomarkers Consortium.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1956-63. doi: 10.2215/CJN.02590315. Epub 2015 Sep 8.

15.

Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study.

Kummer AE, Grams M, Lutsey P, Chen Y, Matsushita K, Köttgen A, Folsom AR, Coresh J.

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2023-9. doi: 10.2215/CJN.10111014. Epub 2015 Sep 4.

16.

The effects of weight change on glomerular filtration rate.

Chang A, Greene TH, Wang X, Kendrick C, Kramer H, Wright J, Astor B, Shafi T, Toto R, Lewis J, Appel LJ, Grams M.

Nephrol Dial Transplant. 2015 Nov;30(11):1870-7. doi: 10.1093/ndt/gfv219. Epub 2015 Jun 17.

18.

Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients.

McAdams-DeMarco MA, Law A, Tan J, Delp C, King EA, Orandi B, Salter M, Alachkar N, Desai N, Grams M, Walston J, Segev DL.

Transplantation. 2015 Apr;99(4):805-10. doi: 10.1097/TP.0000000000000444.

19.

Increasing active travel: aims, methods and baseline measures of a quasi-experimental study.

Chapman R, Howden-Chapman P, Keall M, Witten K, Abrahamse W, Woodward A, Muggeridge D, Beetham J, Grams M.

BMC Public Health. 2014 Sep 8;14:935. doi: 10.1186/1471-2458-14-935.

20.

Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.

Selvin E, Rawlings AM, Grams M, Klein R, Steffes M, Coresh J.

Clin Chem. 2014 Nov;60(11):1409-18. doi: 10.1373/clinchem.2014.229427. Epub 2014 Sep 8.

Supplemental Content

Loading ...
Support Center